Glenn J. Hanna, MD | Authors

Articles

Nivolumab Reduces Transformation of Precancerous Leukoplakia to Oral Cancer

October 17, 2022

Video

Glenn J. Hanna, MD, discusses the results of a study investigating nivolumab as treatment for proliferative leukoplakia leading to oral cancer.

Proliferative Leukoplakia and Oral Cancer Transformation

October 12, 2022

Video

Glenn J. Hanna, MD, discusses proliferative leukoplakia and risk of oral cancer.

Integrating Immunotherapy With Chemoradiation in the Treatment of Head and Neck Cancer

July 06, 2016

Article

Squamous cell carcinoma of the head and neck (SCCHN) is an immunosuppressive disease, as its patients often demonstrate immune dysregulation that correlates with poorer outcomes. Trials are underway combining chemoradiotherapy with immune checkpoint inhibitors.